Due to the increased understandings of tumor biology and the signal pathways involved in lung cancer cells proliferation, several novel targeted agents that blocking dysregulated signaling pathways, such as EGFR and vascular endothelial growth factor (VEGF) pathways have been introduced. The gene discussed is EGFR; the disease is neoplasm.